Thursday October 25, 2018

Day one morning

New technologies and Partnership Opportunities in Drug Delivery on Conference

Drug Delivery and Formulation Strategies

Thursday,Friday, Oct.25-26, 2018
Session One

Oral formulation development and design

Session Two

Injection development and design

Session Three

Inhalation development and design

Related Event



With the main business of bioanalysis, Finelyse Pharmaceutical company focuses on bioequivalence (BE) and pharmacokinetic (PK) sample analysis an testing, while provides “one-step” services on BE and PK research.

The company’s core team has more than 30 years of clinical pharmacy and biopharmaceutical research experience, and strictly implements the quality policy of “scientific design, regulatory compliance, accurate results and efficient process”, which has a good overall control ability for the project. In collaboration with clinical hospitals, we have accumulated research experience in high-variation drugs, endogenous drugs and ultra-low concentration drugs, and forming a technological advantage.

Download Brochure

DDF2018 Partners
  • Shanghai Bocimed Pharmaceutical Co.,Ltd
  • unchained Labs
  • yingkerui
  • IMPACT Scientific Instrument Co.,Ltd
  • EverPro Medical Co., Ltd.
  • Shandong Bestcomm
  • Fanweixi
  • AUSTAR Group
Media Partner
  • phex
  • pharma china
  • dxy
  • bio-equip
  • GBI
  • Bioon
  • Lingmed
  • yqxxeng
  • PharmaFocusAsia
  • PharmaVision
  • pharmaphorum
  • Drug Development
  • ipt
  • bio1000
Contact Us

Luke Xia